GIW is a clinical stage company creating a new category in healthcare designed to create less invasive surgery & reduce healthcare costs.
GI Windows is dedicated to developing the first fundamental breakthrough in anastomoses technology in both delivery and tissue fusion.
GI Windows was founded in 2012. The company is headquartered in West Bridgewater, Massachusetts. GI Windows was spun out of Beacon Endoscopic (acquired by Covidien in 2014).
GI Windows is creating a paradigm shift to make surgery less invasive, by leveraging the natural orifice in the body.
The GI Windows technology has the potential to create a new paradigm for assessing risk profiles in surgical procedures, improving access to care and enabling new procedures to make a tremendous impact on patient.
GI Windows is backed by Johnson & Johnson Innovation – JJDC, Inc., GT Healthcare Capital Partners, Sonder Capital, JC Investco, ennedy Trust, Coleman Trust and others. The company raised $16.4M in Series A-1 rounds on Aug 19, 2020. This brings GI's total funding to $42.1M to date.